Optimal Research and OncoLens partner to usher JIT Clinical Trials for Cancer patients

Optimal Research, a patient identification and trial activation service provider, and OncoLens, a software as a service (SaaS) tumor board solution asserted to partner to bring treatment options to community cancer centers and their patients faster through Optimal Research’s unique just-in-time (JIT) model.

JIT an “on demand” delivery method for cancer treatment  through clinical research that reduces redundancies often found in the startup of clinical trials. As a result, a trial can be initiated in as few as 10 days for even one qualifying patient.

The partnership expands options to find the best treatment for patients and provide that treatment locally. Together, Optimal Research and OncoLens enable both doctors and patients to access some of the most innovative research options in the United States.

Krystyna Kowalczyk, COO of Optimal Research said “Our partnership with OncoLens allows doctors to offer their patients clinical trials from a full portfolio of opportunities, and enables their patients to remain at their home treatment centers, in close proximity to their personal support systems.”